Literature DB >> 3435103

Activity of terbinafine in experimental fungal infections of laboratory animals.

G Petranyi1, J G Meingassner, H Mieth.   

Abstract

The allylamine derivative terbinafine is the first antifungal agent with primary fungicidal properties against dermatophytes which acts systemically after oral application as well as locally after topical application. Comparative oral studies carried out with griseofulvin and ketoconazole in model infections such as guinea pig trichophytosis and microsporosis revealed terbinafine to be superior to the reference compounds both clinically and mycologically. An excellent antimycotic activity of terbinafine was also demonstrable after topical treatment of guinea pig dermatophytoses caused by Trichophyton mentagrophytes or Microsporum canis. Results of comparative chemotherapeutic studies carried out with econazole and tolnaftate demonstrated superior efficacy of terbinafine in the treatment of both trichophytosis and microsporosis. Skin infections of guinea pigs caused by Candida albicans and vaginal candidiasis in rats proved to be responsive to a topical application of terbinafine also. However, the reference compounds, clotrimazole and miconazole, exhibited activity superior to that of terbinafine in both models.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435103      PMCID: PMC174989          DOI: 10.1128/AAC.31.10.1558

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  In-vitro studies with SF 86-327, a new orally active allylamine derivative.

Authors:  S Shadomy; A Espinel-Ingroff; R J Gebhart
Journal:  Sabouraudia       Date:  1985-04

2.  Synthesis and antifungal activity of (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphtha lenemethanamine (SF 86-327) and related allylamine derivatives with enhanced oral activity.

Authors:  A Stütz; G Petranyi
Journal:  J Med Chem       Date:  1984-12       Impact factor: 7.446

3.  The "hair root invasion test", a semi-quantitative method for experimental evaluation of antimycotics in guinea-pigs.

Authors:  G Petranyi; I Leitner; H Mieth
Journal:  Sabouraudia       Date:  1982-06

4.  [Deep-freeze preservation of fungi in liquid nitrogen as a basis for standardized inocula].

Authors:  A Georgopoulos
Journal:  Mykosen       Date:  1978-01

5.  [In vitro spectrum of action of a new antifungal derivative of naftifin: terbinafin (SF 86-327)].

Authors:  M Goudard; Y Buffard; H Ferrari; P Regli
Journal:  Pathol Biol (Paris)       Date:  1986-06

6.  Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase.

Authors:  G Petranyi; N S Ryder; A Stütz
Journal:  Science       Date:  1984-06-15       Impact factor: 47.728

  6 in total
  16 in total

1.  Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  K Lazardi; J A Urbina; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.

Authors:  T Arika; M Yokoo; T Hase; T Maeda; K Amemiya; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 3.  In vitro and in vivo evaluation of antifungal agents.

Authors:  A Espinel-Ingroff; S Shadomy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

4.  Inactivity of terbinafine in a rat model of pulmonary aspergillosis.

Authors:  H J Schmitt; J Andrade; F Edwards; Y Niki; E Bernard; D Armstrong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

5.  In vitro profiling of pramiconazole and in vivo evaluation in Microsporum canis dermatitis and Candida albicans vaginitis laboratory models.

Authors:  Kelly de Wit; Caroline Paulussen; An Matheeussen; Koen van Rossem; Paul Cos; Louis Maes
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

6.  In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis.

Authors:  D M Saunte; F Simmel; N Frimodt-Moller; L B Stolle; E L Svejgaard; M Haedersdal; C Kloft; M C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

7.  Terbinafine resistance mediated by salicylate 1-monooxygenase in Aspergillus nidulans.

Authors:  Marcia A S Graminha; Eleusa M F Rocha; Rolf A Prade; Nilce M Martinez-Rossi
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.

Authors:  R A Maldonado; J Molina; G Payares; J A Urbina
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

9.  Comparison of the effects of three different anti-fungus drugs on Candida albicans of murine vaginal mucosa.

Authors:  Shanjuan Chen; Shaohua Li; Zhixiang Liu; Yan Wu; Yating Tu; Jiawen Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

Review 10.  Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.

Authors:  J A Balfour; D Faulds
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.